Results 161 to 170 of about 4,350 (187)
Some of the next articles are maybe not open access.
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Nature Medicine, 2022Andreas Mackensen, Sebastian Boeltz
exaly
Drug-induced subacute cutaneous lupus erythematosus
Lupus, 2010Subacute cutaneous lupus erythematosus (SCLE) is a subset of cutaneous lupus erythematosus with unique immunologic and clinical features. The first description dates back to 1985 when a series of five patients were found to have hydrochlorothiazide-induced SCLE.
openaire +2 more sources
Nitrendipine-induced subacute cutaneous lupus erythematosus.
European journal of dermatology : EJD, 2003A 66-year-old man presented with widespread annular and bullous subacute cutaneous lupus erythematosus (SCLE), developed after starting treatment for hypertension with the calcium channel blocker nitrendipine. A few days after withdrawal of the drug, while cutaneous manifestations were improving, left hemiparesis occurred.
Marzano, Angelo V +4 more
openaire +2 more sources
Global epidemiology of systemic lupus erythematosus
Nature Reviews Rheumatology, 2021Megan R W Barber +2 more
exaly
Subacute Cutaneous Lupus Erythematosus
Mayo Clinic Proceedings, 2017Dema T. Alniemi +3 more
openaire +1 more source
[Subacute cutaneous lupus erythematosus].
Harefuah, 1986D, Huminer, D, Shvili
openaire +3 more sources
Subacute cutaneous lupus erythematosus
2018Lisa Pappas-Taffer, Jeffrey P. Callen
openaire +1 more source
New insights into the immunopathogenesis of systemic lupus erythematosus
Nature Reviews Rheumatology, 2016George C Tsokos +2 more
exaly